Position in JNJ
as of Jun 30, 2026
· filed Jul 17, 2026
Position Value
$51,623,719
+$4,092,117 QoQ
Shares Held
203,267
+4.5% QoQ
Ownership
0.008%
of shares outstanding
% of Portfolio
0.59%
of 13F equity value
Holder Rank
#439
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Derivatives in JNJ
reported options exposure · as of Jun 30, 2026CallValue
$0
CallShares
0
PutValue
$838,101
PutShares
3,300
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Sequoia Financial Advisors, LLC holds $404,940,719 across 16 Drug Manufacturers - General names. JNJ ranks #3 (12.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
154,543 | $185,363,525 | |
| 2 | AMGN |
Amgen Inc
|
173,024 | $62,655,450 | |
| 3 | JNJ |
Johnson & Johnson
This page
|
203,267 | $51,623,719 | |
| 4 | MRK |
Merck & Co., Inc.
|
292,117 | $37,537,034 | |
| 5 | ABBV |
AbbVie Inc.
|
94,884 | $23,876,609 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
179,874 | $10,364,339 | |
| 7 | PFE |
Pfizer Inc
|
332,178 | $7,998,846 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
58,662 | $7,411,357 |
All Filings in JNJ
Export CSV
33 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $838,101 | 3,300 | Put | Sole | 2026-07-17 | |
| 2026-06-30 | $51,623,719 | 203,267 | Shares | Sole | 2026-07-17 | |
| 2026-03-31 | $2,102,184 | 8,600 | Put | Sole | 2026-04-30 | |
| 2026-03-31 | $47,531,602 | 194,451 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $1,862,550 | 9,000 | Put | Sole | 2026-02-03 | |
| 2025-12-31 | $38,864,796 | 187,798 | Shares | Sole | 2026-02-03 | |
| 2025-09-30 | $34,263,020 | 184,786 | Shares | Sole | 2025-10-29 | |
| 2025-09-30 | $686,054 | 3,700 | Put | Sole | 2025-10-29 | |
| 2025-06-30 | $748,475 | 4,900 | Put | Sole | 2025-07-25 | |
| 2025-06-30 | $38,695,241 | 253,324 | Shares | Sole | 2025-07-25 | |
| 2025-03-31 | $812,616 | 4,900 | Put | Sole | 2025-04-23 | |
| 2025-03-31 | $40,210,727 | 242,467 | Shares | Sole | 2025-04-23 | |
| 2024-12-31 | $35,339,198 | 244,359 | Shares | Sole | 2025-08-08 | |
| 2024-12-31 | $723,100 | 5,000 | Put | Sole | 2025-08-08 | |
| 2024-09-30 | $37,831,448 | 233,441 | Shares | Sole | 2024-10-21 | |
| 2024-06-30 | $13,931,971 | 95,320 | Shares | Sole | 2024-07-15 | |
| 2024-03-31 | $15,715,701 | 99,347 | Shares | Sole | 2024-04-30 | |
| 2023-12-31 | $14,472,901 | 92,337 | Shares | Sole | 2024-01-26 | |
| 2023-09-30 | $8,375,923 | 53,778 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $9,155,904 | 55,316 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $8,159,045 | 52,639 | Shares | Sole | 2023-04-25 | |
| 2022-12-31 | $9,298,679 | 52,639 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $5,168,547 | 31,639 | Shares | Sole | 2022-10-26 | |
| 2022-06-30 | $6,934,960 | 39,068 | Shares | Sole | 2022-07-22 | |
| 2022-03-31 | $6,843,559 | 38,614 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $6,379,371 | 37,291 | Shares | Sole | 2022-02-22 | |
| 2021-09-30 | $1,411,671 | 8,741 | Shares | Sole | 2021-10-26 | |
| 2021-06-30 | $4,959,168 | 30,103 | Shares | Sole | 2021-07-27 | |
| 2021-03-31 | $4,409,181 | 26,828 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $3,755,086 | 23,860 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $3,465,926 | 23,280 | Shares | Sole | 2020-10-23 | |
| 2020-06-30 | $2,924,541 | 20,796 | Shares | Sole | 2020-08-25 | |
| 2020-03-31 | $2,545,757 | 19,414 | Shares | Sole | 2020-05-11 | |
| No filing history on record for this holder in this stock. | ||||||